Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169


Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Wang S, Goguen JD, Li F, Lu S.

Vaccine. 2011 Sep 9;29(39):6802-9. doi: 10.1016/j.vaccine.2010.12.062. Epub 2011 Jan 1.


Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.

Miller NC, Quenee LE, Elli D, Ciletti NA, Schneewind O.

Infect Immun. 2012 Apr;80(4):1572-82. doi: 10.1128/IAI.05637-11. Epub 2012 Jan 17.


Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.

Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.

Eur J Immunol. 2010 Oct;40(10):2791-6. doi: 10.1002/eji.201040511.


A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S.

Vaccine. 2004 Sep 3;22(25-26):3348-57.


Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.

Torres-Escobar A, Juárez-Rodríguez MD, Gunn BM, Branger CG, Tinge SA, Curtiss R 3rd.

Infect Immun. 2010 Jun;78(6):2529-43. doi: 10.1128/IAI.00005-10. Epub 2010 Mar 22.


Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.

Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.

Vaccine. 2008 Nov 25;26(50):6329-37. doi: 10.1016/j.vaccine.2008.09.031. Epub 2008 Oct 1.


Cell-mediated protection against pulmonary Yersinia pestis infection.

Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST.

Infect Immun. 2005 Nov;73(11):7304-10.


TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST.

Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15.


Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R 3rd.

Vaccine. 2010 Dec 16;29(2):274-82. doi: 10.1016/j.vaccine.2010.10.033. Epub 2010 Oct 24.


Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.

Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.

Vaccine. 2008 Mar 20;26(13):1616-25. doi: 10.1016/j.vaccine.2008.01.033. Epub 2008 Feb 6.


Yersinia pestis V protein epitopes recognized by CD4 T cells.

Parent MA, Berggren KN, Mullarky IK, Szaba FM, Kummer LW, Adamovicz JJ, Smiley ST.

Infect Immun. 2005 Apr;73(4):2197-204.


Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.

Gupta G, Ali R, Khan AA, Rao DN.

Int Immunopharmacol. 2012 Jan;12(1):64-73. doi: 10.1016/j.intimp.2011.10.012. Epub 2011 Nov 15.


Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.

Shreewastav RK, Ali R, Uppada JB, Rao DN.

Cell Immunol. 2012 Jul-Aug;278(1-2):55-62. doi: 10.1016/j.cellimm.2012.07.002. Epub 2012 Jul 20.


Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Bhattacharya D, Mecsas J, Hu LT.

Vaccine. 2010 Nov 10;28(48):7683-9. doi: 10.1016/j.vaccine.2010.09.039. Epub 2010 Sep 25.


TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.

Szaba FM, Kummer LW, Duso DK, Koroleva EP, Tumanov AV, Cooper AM, Bliska JB, Smiley ST, Lin JS.

PLoS Pathog. 2014 May 22;10(5):e1004142. doi: 10.1371/journal.ppat.1004142. eCollection 2014 May 22.


HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.

Batra L, Verma SK, Nagar DP, Saxena N, Pathak P, Pant SC, Tuteja U.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3322. doi: 10.1371/journal.pntd.0003322. eCollection 2014 Dec 4.


Protection against pneumonic plague following oral immunization with a non-replicating vaccine.

Jones A, Bosio C, Duffy A, Goodyear A, Schriefer M, Dow S.

Vaccine. 2010 Aug 16;28(36):5924-9. doi: 10.1016/j.vaccine.2010.06.020. Epub 2010 Jun 19.

Supplemental Content

Support Center